Literature DB >> 20400463

Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions.

Laura Amanzi1, Francesca Braschi, Ginevra Fiori, Felice Galluccio, Irene Miniati, Serena Guiducci, Maria-Letizia Conforti, Olga Kaloudi, Francesca Nacci, Oana Sacu, Antonio Candelieri, Alberto Pignone, Laura Rasero, Domenico Conforti, Marco Matucci-Cerinic.   

Abstract

OBJECTIVE: To evaluate in SSc, the frequency of digital lesions and the morphology, characteristics, natural course and time to healing of 1614 digital ulcers (DUs).
METHODS: One hundred SSc patients were followed up for 4 years. In the first step, the digital lesions were observed and classified at the time of presentation [digital pitting scar (DPS); DU; calcinosis; gangrene]. In the second step, DUs were divided into subsets according to their origin and main features. In the third step, the time to healing was recorded for each DU and the influence of DU main characteristics on time to healing was also evaluated.
RESULTS: In the first step, 1614 digital lesions were observed: DPS, 712 (44.1%) lesions; DU, 785 (48.6%); calcinosis, 110 (6.8%); and gangrene, 7 (0.8%). In the second step, DUs were subsetted as follows: DU developed on DPS (8.8%), pure DU; DU developed on calcinosis (60%); DU derived from gangrene. In the third step, the mean time to healing was 25.6 (15.6) days in DPS, 76.2 (64) days in pure DU, 93.6 (59.2) days in calcinosis ulcers and 281.1 (263.3) in gangrene.
CONCLUSIONS: In SSc, digital lesions are represented by DPS, DU, calcinosis and gangrene, and provide an evidence-based DU subsetting according to their origin and main characteristics. Subsetting may be helpful for a precise DU evaluation and staging, and in randomized controlled trials for a precise identification of those DUs that are to be included in therapeutic studies.

Entities:  

Mesh:

Year:  2010        PMID: 20400463     DOI: 10.1093/rheumatology/keq097

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  43 in total

1.  Biomechanical podiatric evaluation in an Italian cohort of patients with systemic sclerosis: A pilot study.

Authors:  Susanna Maddali Bongi; Giovanni Ravenni; Benedetta Ciampi; Angela Del Rosso; Khadija El Aoufy
Journal:  Eur J Rheumatol       Date:  2016-12-01

2.  Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis.

Authors:  Ivone Silva; Cristiana Almeida; Andreia Teixeira; José Oliveira; Carlos Vasconcelos
Journal:  Clin Rheumatol       Date:  2016-02-26       Impact factor: 2.980

3.  Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.

Authors:  Jelena Blagojevic; G Abignano; J Avouac; L Cometi; M Frerix; S Bellando-Randone; S Guiducci; C Bruni; D Huscher; V K Jaeger; V Lóránd; B Maurer; S Nihtyanova; G Riemekasten; E Siegert; I H Tarner; S Vettori; U A Walker; L Czirják; C P Denton; O Distler; Y Allanore; U Müller-Ladner; A Moggi-Pignone; M Matucci-Cerinic; F Del Galdo
Journal:  Clin Rheumatol       Date:  2019-05-20       Impact factor: 2.980

Review 4.  Points to consider-Raynaud's phenomenon in systemic sclerosis.

Authors:  Maurizio Cutolo; Vanessa Smith; Daniel E Furst; Dinesh Khanna; Ariane L Herrick
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

5.  Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.

Authors:  Ivone Silva; Andreia Teixeira; José Oliveira; Isabel Almeida; Rui Almeida; Artur Águas; Carlos Vasconcelos
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 6.  Raynaud phenomenon and digital ulcers in systemic sclerosis.

Authors:  Michael Hughes; Yannick Allanore; Lorinda Chung; John D Pauling; Christopher P Denton; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2020-02-25       Impact factor: 20.543

7.  The critical need for accurately defining digital ulcers in scleroderma.

Authors:  Wendy Li; Tracy M Frech
Journal:  J Scleroderma Relat Disord       Date:  2017-05-19

8.  Registry evaluation of digital ulcers in systemic sclerosis.

Authors:  Felice Galluccio; Marco Matucci-Cerinic
Journal:  Int J Rheumatol       Date:  2010-08-25

9.  Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study.

Authors:  F Cozzi; E Pigatto; M Rizzo; M Favaro; E Zanatta; S Cardarelli; L Riato; L Punzi
Journal:  Clin Rheumatol       Date:  2013-01-24       Impact factor: 2.980

10.  Endocan, Novel Potential Biomarker for Systemic Sclerosis: Results of a Pilot Study.

Authors:  Paul Bălănescu; Anca Lădaru; Eugenia Bălănescu; Theodor Voiosu; Cristian Băicuş; Gheorghe Andrei Dan
Journal:  J Clin Lab Anal       Date:  2015-09-01       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.